Research output

PET imaging of zirconium-89 labelled cetuximab: A phase I trial in patients with head and neck and lung cancer

Research output: Contribution to journalArticleAcademicpeer-review

Associated researcher

Associated organisations

    Research areas

  • Zr-89-cetuximab, EGFR, Immuno-PET, Phase I trial, GROWTH-FACTOR RECEPTOR, MONOCLONAL-ANTIBODIES, PLUS CETUXIMAB, 1ST-LINE CHEMOTHERAPY, EGFR-INHIBITION, IMMUNO-PET, EXPRESSION, RADIOTHERAPY, CARCINOMA, SURVIVAL
View graph of relations

Details

Original languageEnglish
Pages (from-to)267-273
Number of pages7
JournalRadiotherapy and Oncology
Volume122
Issue number2
DOIs
Publication statusPublished - Feb 2017